KELLY WILLIAMS: Open Payments
NPI 1952015497 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 35 payments from 11 companies in 2025. Trend: 2023 $275 · 2024 $1,007 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $209 |
| GlaxoSmithKline, LLC. | 5 | $202 |
| JAZZ PHARMACEUTICALS INC. | 1 | $131 |
| Regeneron Healthcare Solutions, Inc. | 5 | $128 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| Verona Pharma, Inc. | 3 | $63 |
| Grifols USA, LLC | 1 | $32 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $20 |
Products named: DUPIXENT, NUCALA, XYWAV, AIRSUPRA, TRELEGY ELLIPTA, Ohtuvayre, TEZSPIRE, Prolastin-C Liquid.
Industry payments across AL — which companies pay providers there.
